Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets - PubMed

Affiliations

• PMID: 7795224

Free article

Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets

Y Yatomi et al. Blood. 1995.

Free article

Abstract

Sphingosine-1-phosphate (Sph-1-P) is the initial product of catabolism of sphingosine by sphingosine kinase and is cleaved by Sph-1-P lyase to a fatty aldehyde and ethanolamine phosphate. This phosphorylated sphingoid base is not only an intermediary catabolite, but also a bioactive lipid with important functions, including stimulation of cell proliferation in Swiss 3T3 fibroblasts and inhibition of tumor cell motility. In the present study, we examined functional roles of Sph-1-P in human platelets. Sph-1-P induced platelet shape change and aggregation reactions, although it failed to elicit secretion. Sphingosine, ceramide, sphingomyelin, and N,N-dimethylsphingosine did not mimic the positive effects of Sph-1-P on platelets. Subthreshold concentrations of Sph-1-P and weak platelet agonists such as adenosine diphosphate (ADP) and epinephrine synergistically elicited aggregation, which may be important for efficient amplification of platelet activation. Sph-1-P induced intracellular Ca2+ mobilization and the dose-response for Ca2+ release correlated closely with the concentration required for induction of shape change. On addition of [3H]sphingosine to intact platelets, the label was rapidly converted to Sph-1-P, and subsequently to ceramide and sphingomyelin. Interestingly, the Sph-1-P formed was specifically released into medium on stimulation of platelets with physiologic agonists. The amount of Sph-1-P in platelets, as measured by its conversion into radiolabeled N-acetyl-Sph-1-P, was 1.4 nmol/10(9) cells and was about four times higher than the mass of Sph present. When compared by mole percent Sph-1-P/phospholipid, the value for platelets is over 10 times higher than that for neutrophils. Our results suggest that Sph-1-P, rapidly converted from sphingosine, abundantly stored in platelets, and released on the cell activation, may play a physiologic role in thrombosis, hemostasis, and the natural wound-healing processes.

Similar articles

• N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets.

  Yatomi Y, Ruan F, Megidish T, Toyokuni T, Hakomori S, Igarashi Y. Yatomi Y, et al. Biochemistry. 1996 Jan 16;35(2):626-33. doi: 10.1021/bi9515533. Biochemistry. 1996. PMID: 8555236

• Quantification of sphingosine derivatives in human platelets: inducible formation of free sphingosine.

  Hisano N, Yatomi Y, Fujino MA, Igarashi Y, Kume S, Ozaki Y. Hisano N, et al. J Biochem. 1998 Feb;123(2):263-8. doi: 10.1093/oxfordjournals.jbchem.a021931. J Biochem. 1998. PMID: 9538201

• Sphingosine 1-phosphate formation and intracellular Ca2+ mobilization in human platelets: evaluation with sphingosine kinase inhibitors.

  Yang L, Yatomi Y, Satoh K, Igarashi Y, Ozaki Y. Yang L, et al. J Biochem. 1999 Jul;126(1):84-9. doi: 10.1093/oxfordjournals.jbchem.a022440. J Biochem. 1999. PMID: 10393324

• Sphingosine 1-phosphate: synthesis and release.

  Yatomi Y, Ozaki Y, Ohmori T, Igarashi Y. Yatomi Y, et al. Prostaglandins Other Lipid Mediat. 2001 Apr;64(1-4):107-22. doi: 10.1016/s0090-6980(01)00103-4. Prostaglandins Other Lipid Mediat. 2001. PMID: 11324700 Review.

Cited by

• Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.

  Okamoto H, Takuwa N, Yokomizo T, Sugimoto N, Sakurada S, Shigematsu H, Takuwa Y. Okamoto H, et al. Mol Cell Biol. 2000 Dec;20(24):9247-61. doi: 10.1128/MCB.20.24.9247-9261.2000. Mol Cell Biol. 2000. PMID: 11094076 Free PMC article.

• Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine.

  Hemmings DG. Hemmings DG. Naunyn Schmiedebergs Arch Pharmacol. 2006 Apr;373(1):18-29. doi: 10.1007/s00210-006-0046-5. Naunyn Schmiedebergs Arch Pharmacol. 2006. PMID: 16570136 Review.

• Cortical Actin Dynamics in Endothelial Permeability.

  Belvitch P, Htwe YM, Brown ME, Dudek S. Belvitch P, et al. Curr Top Membr. 2018;82:141-195. doi: 10.1016/bs.ctm.2018.09.003. Epub 2018 Oct 15. Curr Top Membr. 2018. PMID: 30360779 Free PMC article.

• Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase.

  Maines LW, Fitzpatrick LR, French KJ, Zhuang Y, Xia Z, Keller SN, Upson JJ, Smith CD. Maines LW, et al. Dig Dis Sci. 2008 Apr;53(4):997-1012. doi: 10.1007/s10620-007-0133-6. Epub 2007 Dec 4. Dig Dis Sci. 2008. PMID: 18058233 Free PMC article.

• Roles and regulation of secretory and lysosomal acid sphingomyelinase.

  Jenkins RW, Canals D, Hannun YA. Jenkins RW, et al. Cell Signal. 2009 Jun;21(6):836-46. doi: 10.1016/j.cellsig.2009.01.026. Cell Signal. 2009. PMID: 19385042 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal